openPR Logo
Press release

Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market is anticipated to grow at a CAGR of 18.3% and 20%, respectively, predicts Roots Analysis

07-28-2025 01:23 PM CET | Health & Medicine

Press release from: Roots Analysis

Deep Learning in Drug Discovery and Deep Learning in Diagnostics

Increased capital investments and higher attrition rates have prompted the implementation of deep learning technologies to expedite drug discovery process; early-stage diagnostic capability of such technologies has also emerged as a key driver for their adoption

Roots Analysis is pleased to announce the publication of its recent study, titled, "Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market (2nd Edition)"

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/deep-learning-in-drug-discovery-market/request-quote.html

The report features an extensive study of the current market landscape and the likely future potential of the deep learning solutions market within the healthcare domain. The report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry. Amongst other elements, the report includes:
1. An executive summary of the insights captured during our research, offering a high-level view on the current state of deep learning market for drug discovery and diagnostics and its likely evolution in the mid-to-long term.
2. A general overview of big data revolution in the medical industry, along with information on artificial intelligence, machine learning and deep learning algorithms.
3. A detailed assessment of the market landscape of more than 70 companies offering deep learning technologies / services for the purpose of drug discovery, based on several relevant parameters.
4. A detailed assessment of the market landscape of more than 130 companies offering deep learning technologies / services for diagnostics, based on several relevant parameters.
5. Elaborate profiles of key players developing technologies and offering services related to deep learning, specifically for drug discovery and diagnostics.
6. A qualitative analysis, highlighting the five competitive forces prevalent in the deep learning domain.
7. An analysis of completed and ongoing clinical trials related to deep learning, based on several relevant parameters.
8. A detailed analysis of various investments made by players engaged in this domain, during the period 2019-2022, based on several relevant parameters.
9. An analysis of the start-ups / small players (established post 2015, with less than 50 employees) engaged in the deep learning market focused on drug discovery and diagnostics.
10. An elaborate valuation analysis of companies that are involved in the deep learning in drug discovery and diagnostics market, based on our proprietary, multi-variable dependent valuation model to estimate the current valuation / net worth of industry players.

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/deep-learning-in-drug-discovery-market/request-sample.html

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
A. Therapeutic Area
1. Oncological Disorders
2. Infectious Diseases
3. Neurological Disorders
4. Immunological Disorders
5. Endocrine Disorders
6. Cardiovascular Disorders
7. Respiratory Disorders
8. Ophthalmic Disorders
9. Musculoskeletal Disorders
10. Other Disorders
B. Key Geographical Regions
1. North America
2. Europe
3. Asia Pacific
4. Rest of the World

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/deep-learning-in-drug-discovery-market/156.html

Key companies / organizations covered in the report
1. Aegicare
2. Aiforia Technologies
3. Ardigen
4. Berg
5. Google
6. Huawei
7. Merative
8. Nference
9. Nvidia
10. Owkin
11. Phenomic AI
12. Pixel AI

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market is anticipated to grow at a CAGR of 18.3% and 20%, respectively, predicts Roots Analysis here

News-ID: 4122654 • Views:

More Releases from Roots Analysis

Industrial Robotics Market to Reach USD 39.03 Billion by 2035, Driven by Rising Automation Demand Across Manufacturing | Roots Analysis
Industrial Robotics Market to Reach USD 39.03 Billion by 2035, Driven by Rising …
09-04-2025 | Robotics & Automation Press release from: Roots Analysis According to Roots Analysis' latest industry report titled "Industrial Robotics Market: Industry Trends and Global Forecasts, till 2035", the global industrial robotics market is projected to grow from USD 17.64 billion in 2024 to USD 18.80 billion in 2025, reaching USD 39.03 billion by 2035 at a CAGR of 7.5% during the forecast period. To request a quote for this report, visit: https://www.rootsanalysis.com/industrial-robotics-market/request-quote Market Overview Industrial
Targeted Drug Delivery Device Market Size to reach USD 2,153 million by 2035 | Roots Analysis
Targeted Drug Delivery Device Market Size to reach USD 2,153 million by 2035 | R …
According to our latest market report "Targeted Drug Delivery Device Market" by Type of Device, Target Organ, Type of Therapy Delivered, Route of Administration, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035", the targeted drug delivery device market size is projected to reach USD 2,153 million by 2035 from USD 427 million in 2026, growing at a CAGR of 19.7% in the forecast period, till
The Conjugation and Labeling Services Market is projected to grow at a CAGR of 10.3%, till 2035, claims Roots Analysis
The Conjugation and Labeling Services Market is projected to grow at a CAGR of 1 …
The complexities associated with conjugation of biomolecules and the need for click-chemistry expertise have prompted the pharmaceutical industry to rely on conjugation and labeling service providers To request quote of this report, please visit: https://www.rootsanalysis.com/reports/conjugation-and-labeling-services-market/request-quote.html Roots Analysis is pleased to announce the publication of its recent study, titled, "Conjugation and Labeling Services Market, 2023-2035" The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies.
Biologics Contract Manufacturing Market CAGR To Exceed 8.8%, Due To The Growing Demand For Biologics | Roots Analysis
Biologics Contract Manufacturing Market CAGR To Exceed 8.8%, Due To The Growing …
According to our latest market report "Biologics Contract Manufacturing Market by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035", the global biologics contract manufacturing market size is projected to reach USD 55.0 billion by 2035 from USD USD 23.8 billion in 2025, growing at a CAGR of 8.8% in the

All 5 Releases


More Releases for Disorders

Bleeding Disorders Market Is Driven By Bleeding Disorders In Various Industries, …
The Bleeding Disorders Market is a critical component of the healthcare industry, focused on the diagnosis, treatment, and management of bleeding disorders that affect individuals' blood clotting mechanisms. These disorders, which include hemophilia, von Willebrand disease, and various clotting factor deficiencies, can lead to prolonged and spontaneous bleeding, posing significant health risks. This market encompasses a range of therapies, medications, and diagnostic tools designed to address the unique needs of
Gene Therapy For Rare Disease Market By Therapeutic Application ( Oncology, Neur …
The Gene Therapy For Rare Disease Market report outlines the evolution of Gene Therapy For Rare Disease industry by type, applications and identifies and assesses the best performing vendors in the market till 2028. Gene Therapy For Rare Disease Market reports present the revenue opportunities in the Gene Therapy For Rare Disease industry through 2023-2028, highlighting the market size and growth by technology, geography, vertical and End users. Download Sample PDF
Neuroprosthetics Market 2019 Industry Segmentation by physiological disorders ar …
Neuroprosthetics Market 2019 Scenario Neuroprosthetics Market was estimated to be USD 5.28 billion in 2016 and expected to reach USD 10.48 billion by 2023. The key factors responsible for driving this are increasing in geriatric population, auditory processing disorders in kids, and increase in spinal cord treatment due to advancement in neuroprosthetics devices. The factors responsible for the positive growth of this market are increasing prevalence of neural diseases, over active bladder
11-29-2018 | Health & Medicine
Fact.MR
Global Vocal Biomarker Market to Experience Significant Growth during the Foreca …
Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known as Vocal Biomarker Market by combining the concept of biological markers with the aforementioned methodology to analyze personality traits. Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=719 These vocal biomarkers are
Behavioral Therapy Market Report 2018: Segmentation by Type (Anxiety Disorders, …
Global Behavioral Therapy market research report provides company profile for American Addiction Centers, ChanceLight, Haven Behavioral Healthcare, Behavioral Health Group, Center for Autism & Related Disorders, People’s Care, Magellan Health, Universal Health Services, Acadia Healthcare, Springstone and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY
Biopharmaceuticals Market Outlook 2025|( Biopharmaceuticals Application:- Infect …
Global Biopharmaceuticals Market Research Report Brief Focus On Study About Biopharmaceuticals Market Industry volume, Market Revenue, Market Segments , Market Trends ,Growth aspects A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report such as: Biopharmaceuticals Product Type:- Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines, Biopharmaceuticals Application :- Inflammatory , Infectious Diseases, Autoimmune Disorders, Metabolic